Extracellular vesicle-based drug delivery systems for cancer treatment

Sierra Walker, Sara Busatto, Anthony Pham, Ming Tian, Annie Suh, Kelsey Carson, Astrid Quintero, Maria Lafrence, Hanna Malik, Moises X. Santana, Joy Wolfram

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Extracellular vesicles (EVs) are naturally occurring cell-secreted nanoparticles that play important roles in many physiological and pathological processes. EVs enable intercellular communication by serving as delivery vehicles for a wide range of endogenous cargo molecules, such as RNAs, proteins, carbohydrates, and lipids. EVs have also been found to display tissue tropism mediated by surface molecules, such as integrins and glycans, making them promising for drug delivery applications. Various methods can be used to load therapeutic agents into EVs, and additional modification strategies have been employed to prolong circulation and improve targeting. This review gives an overview of EV-based drug delivery strategies in cancer therapy.

Original languageEnglish (US)
Pages (from-to)8001-8017
Number of pages17
JournalTheranostics
Volume9
Issue number26
DOIs
StatePublished - Jan 1 2019

    Fingerprint

Keywords

  • Cancer therapy
  • Drug delivery
  • Extracellular vesicle
  • Nanomedicine

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

Walker, S., Busatto, S., Pham, A., Tian, M., Suh, A., Carson, K., Quintero, A., Lafrence, M., Malik, H., Santana, M. X., & Wolfram, J. (2019). Extracellular vesicle-based drug delivery systems for cancer treatment. Theranostics, 9(26), 8001-8017. https://doi.org/10.7150/thno.37097